POM vs YJ
Pomdoctor Limited and Yunji Inc., side by side — 3 fiscal years reported in CNY, drawn from SEC filings.
At a glance
Most recent reported year
| Metric | POM | YJ |
|---|---|---|
| Revenue | ¥399.9M | ¥317.0M |
| Net income | ¥-130.9M | ¥-133.3M |
| Gross margin | 13.1% | 44.4% |
| Net margin | −32.7% | −42.0% |
| Return on equity | — | −13.2% |
| Diluted EPS | −¥21.96 | — |
| Dividend / share | — | — |
| Payout ratio | — | — |
| Free cash flow | ¥-149.5M | ¥-126.6M |
| Equity | ¥-454.0M | ¥935.2M |
| Net debt / equity | — | −0.07× |
| Current ratio | 0.48× | 1.41× |
| Revenue CAGR 5y | — | −43.5% |
| Profit CAGR 5y | — | — |
POM bills 1.3× the revenue of YJ, and both closed the last reported year at a loss.
The stronger figure of the pair is set in bold. That is arithmetic, not a recommendation — this page does not pick a winner.
Advertisement
AdSense · Leaderboard 728×90 · responsive
Revenue by year
3 years side by side
| Fiscal year | POM | YJ |
|---|---|---|
| FY2025 | ¥399.9M | ¥317.0M |
| FY2024 | ¥342.6M | ¥417.7M |
| FY2023 | ¥304.9M | ¥640.2M |
Net income by year
Bottom line
| Fiscal year | POM | YJ |
|---|---|---|
| FY2025 | ¥-130.9M | ¥-133.3M |
| FY2024 | ¥-37.4M | ¥-123.1M |
| FY2023 | ¥-36.9M | ¥-165.1M |
Advertisement
AdSense · Rectangle 336×280
More in this industry